ReviewWorld journal of urology2018
Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.
Review in World journal of urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 36 citations in OpenAlex.
- Paraneoplastic Trichomegaly as a Harbinger of Metastatic Renal Cell Carcinoma: A Case Report.Cureus · 2025Article
- Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma.Cancers · 2024Article
- Renal Cell Carcinoma: A Review.JAMA · 2024Review
- Sweet syndrome with peripheral neuropathy in a patient with metastatic clear cell renal cell carcinoma.BMJ case reports · 2024Article
- Anti-NMDA Receptor Encephalitis Related to Renal Cell Carcinoma: A Case Report.The Neurohospitalist · 2024Article
- Article
- Cushing's syndrome as a paraneoplastic feature of renal cell carcinoma: A case report.Urology case reports · 2023Article
- The relationship between prior psychiatric diagnosis and brain cancer diagnosis in the U.S. military health system.Cancer causes & control : CCC · 2022Article
- Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma.Journal of geriatric oncology · 2022Article
- Transient Receptor Potential Channel 1 Potentially Serves as a Biomarker Indicating T/TNM Stages and Predicting Long-Term Prognosis in Patients With Renal Cell Carcinoma.Frontiers in surgery · 2022Article
- Renal cell carcinoma presenting as painless jaundice and unintentional weight loss.American journal of clinical and experimental urology · 2022Article
- Acute myocardial infarction and arterial embolism in a patient with newly diagnosed renal mass: management dilemmas! A case report.BMC urology · 2021Article
- Myasthenia gravis associated with renal cell carcinoma: a paraneoplastic syndrome or just a coincidence.BMC neurology · 2021Article
- Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma.Current oncology (Toronto, Ont.) · 2021Article
- The frequency of occult solid malignancy in patients with polymyalgia rheumatica-like symptoms.Therapeutic advances in musculoskeletal disease · 2021Article
- Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients.World journal of urology · 2020Article
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis Associated With Clear Cell Renal Carcinoma: A Case Report.Frontiers in oncology · 2020Article
- Paraneoplastic limbic encephalitis cured with nephron-sparing surgery in a patient with clear cell renal cell carcinoma: a case report.The Journal of international medical research · 2019Article
- Eosinophilia and Kidney Disease: More than Just an Incidental Finding?Journal of clinical medicine · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionParaneoplastic syndromes (PNS) in renal cell carcinoma (RCC) are important to be recognized by the treating physician, because they may lead to diagnosis of underlying malignant disease. On the other hand, PNS may dominate the clinical picture and can hide the true disorder like a chameleon. When realized, a PNS can be used as a 'neoplastic tumour marker', especially in case of recurrence. Their occurrence can even be linked to prognosis of disease.
methodsA PubMed search combining the MeSH terms renal cell carcinoma and paraneoplastic syndrome was executed in April 2015. All hits concerning these MeSH terms have been taken into account when writing this review.
resultsThere is a big gap between reporting and incidence of paraneoplastic syndromes in renal cell carcinoma. Most of the articles in Medline are case reports and reviews of research done in the 1950s-1990s. One problem is that a clear definition of a paraneoplastic syndrome is still lacking. The most important PNS in RCC are hypercalcemia. It is important that PNS are not only arising in advanced stages of renal cell carcinoma; in contrast, a PNS can often be the first symptom of RCC.
conclusionParaneoplastic syndromes are often unrecognized but are important biomarkers in RCC. Further research into the underlying pathomechanisms of PNS may improve our understanding of the RCC tumour biology and is urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.